Virax Biolabs Group Limit... (VRAX)
NASDAQ: VRAX
· Real-Time Price · USD
0.62
0.01 (1.54%)
At close: Oct 03, 2025, 3:59 PM
0.62
1.40%
After-hours: Oct 03, 2025, 06:50 PM EDT
1.54% (1D)
| Bid | 0.61 |
| Market Cap | 2.68M |
| Revenue (ttm) | 84.87K |
| Net Income (ttm) | -6.58M |
| EPS (ttm) | -1.62 |
| PE Ratio (ttm) | -0.38 |
| Forward PE | -0.6 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 0.65 |
| Volume | 146,421 |
| Avg. Volume (20D) | 607,353 |
| Open | 0.62 |
| Previous Close | 0.61 |
| Day's Range | 0.61 - 0.63 |
| 52-Week Range | 0.52 - 3.62 |
| Beta | 1.62 |
| Ex-Dividend Date | n/a |
About VRAX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol VRAX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for VRAX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts11 months ago
+50%
Virax Biolabs shares are trading higher after the ...
Unlock content with
Pro Subscription
